close

Clinical Trials

1 188 189 190 191 192 220
Number of results: 4389

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2012-11-14 genetics relating to lung disease

chronic obstructive pulmonary disease (COPD)
lung diseases

genetic study Medical Research Council - MRC (UK) Nottingham University (UK) Leicester University (UK) Respiratory diseases - Lung diseases
2012-11-13 AM-111 acute sensorineural hearing loss (ASNHL) 2b Auris Medical (Switzerland) Otorhinolaryngology
2012-11-13 TG4001 HPV16 positive oropharyngeal squamous cell carcinomas
2b Transgene (France) EORTC (EU) Cancer - Oncology
2012-11-12 TNF-Kinoid® rheumatoid arthritis 2a Neovacs (France) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2012-11-12 CP-4126 2 Clavis Pharma (Norway) - Clovis Oncology (USA) Cancer - Oncology
2012-11-12 MOR103 (antibody targeting granulocyte-macrophage colony-stimulating factor - GM-CSF)

chronic inflammatory diseases

1 Morphosys (Germany) Autoimmune diseases - Inflammatory diseases
2012-11-11 ACZ885 (canakinumab)

Familial Mediterranean Fever (FMF)

2 Novartis (Switzerland) Rare diseases - Inflammatory diseases
2012-11-11 ACZ885 (canakinumab)

tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS)

2 Novartis (Switzerland) Rare diseases - Inflammatory diseases
2012-11-10 type 1 diabetes Sanofi (France) T1D Exchange (USA) Metabolic diseases
2012-11-09 QNASL® (beclomethasone dipropionate)

seasonal allergic rhinitis (SAR)

3 Teva Pharmaceutical Industries (Israel) Allergic diseases - Immune diseases
2012-11-08 T-Track® TB test tuberculosis Lophius Biosciences (Germany) Infectious diseases
2012-11-08 AllerT birch pollen allergy 1-2a Anergis (Switzerland) Allergic diseases - Immunological diseases
2012-11-07 RG7212 advanced solid tumors 1 Roche (Switzerland) Cancer - Oncology
2012-11-07 ATSP-7041 preclinical data Aileron Therapeutics (USA) Roche (Switzerland) Cancer - Oncology
2012-11-06 SAR236553/REGN727

patients with heterozygous familial hypercholesterolemia (heFH)
patients with primary hypercholesterolemia with elevated LDL-C

2 Sanofi (France) Regeneron Pharmaceuticals (USA - NY) Cardiovascular diseases - Genetic diseases - Rare diseases
2012-11-06 PFKFB3 inhibiting compounds pancreatic cancer preclinical data Kancera (Sweden) Cancer - Oncology
2012-11-06 MOR103

rheumatoid arthritis

1b-2a Morphosys (Germany) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2012-11-05 AMG 232 advanced solid tumors, glioblastoma, multiple myeloma 1 Amgen (USA - CA) Cancer - Oncology
2012-11-05 SAR236553/REGN727 evaluation of the incidence of cardiovascular events in patients who have experienced an ACS and are not at their LDL-C goal
3 Sanofi (France) Regeneron Pharmaceutical (USA) Cardiovascular diseases - Metabolic diseases
2012-11-05 ADX71149 (JNJ-40411813) schizophrenia 2a Ortho-McNeil-Janssen Pharmaceuticals J&J (USA) Addex Therapeutics (Switzerland) Mental diseases